Tumour detection assay kit CYFRA21-1 T

for tumor markersserumplasma

This in vitro chemiluminescence immunoassay kit provides quantitative determination of Cytokeratin19 Fragment 21-1 (CYFRA21-1) in human serum and plasma and is intended as an aid in the diagnosis of non-small cell lung cancer. For professional and laboratory use only. Compatible with Chemiluminescence Immunoassay Analyzer C5000.

Key features

• Measurement principle: Chemiluminescence Resonance Energy Transfer (CRET).
• Rapid result: approximately 5 minutes.
• Lyophilized beads formulation for stability across transport conditions.
• Individual packaging to minimize reagent waste.
• No cold chain required within specified storage range.

Storage & Shelf life

• Shelf life: 18 months.
• Storage temperature: 2 - 30°C, protect from direct sunlight.

Strengths

• Lyophilized beads — adaptable to varying transport and storage environments.
• Individual packaging — reduces reagent waste and facilitates inventory control.
• Extended shelf life at ambient conditions — supports decentralized testing scenarios.

Application scenarios

• Point-of-care settings where applicable.
• Emergency and ambulance environments.
• Outpatient departments and clinical wards.
• Clinical laboratories and diagnostic centers.

Technical specifications

• Product name: Cytokeratin19 Fragment 21-1 (CYFRA21-1) Test Kit (Homogeneous Chemiluminescence Immunoassay).
• Commercial name: CYFRA21-1 Test Kit.
• Specification: 25 Tests/Box.
• Sample type: Serum, plasma.
• Applicable instrument: Chemiluminescence Immunoassay Analyzer (C5000).
• Result time: ~5 minutes.
• Shelf life: 18 months.
• Storage conditions: 2 - 30°C, away from sunlight.
• Formulation/packaging: Lyophilized beads, individual packaging.
• Certifications: CE, NMPA.
• Measurement principle: Chemiluminescence Resonance Energy Transfer (CRET).